Legal & General Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-355,278	Closed	-$315K	–	3417
2022 Q4	$315K	Buy	355,278 +25,325	+8%	+$33.6K	﹤0.01%	2452
2022 Q3	$518K	Sell	329,953 -16,028	-5%	-$36.4K	﹤0.01%	2335
2022 Q2	$696K	Buy	345,981 +77,177	+29%	+$133K	﹤0.01%	2268
2022 Q1	$627K	Buy	268,804 +3,143	+1%	+$9.8K	﹤0.01%	2336
2021 Q4	$1.24M	Buy	265,661 +24,990	+10%	+$155K	﹤0.01%	2189
2021 Q3	$1.84M	Buy	240,671 +173,764	+260%	+$1.47M	﹤0.01%	2060
2021 Q2	$649K	Buy	66,907 +6,544	+11%	+$52.1K	﹤0.01%	2294
2021 Q1	$500K	Sell	60,363 -1,962	-3%	-$20.7K	﹤0.01%	2305
2020 Q4	$425K	Buy	62,325 +7,106	+13%	+$57.1K	﹤0.01%	2292
2020 Q3	$616K	Sell	55,219 -2,136	-4%	-$19.5K	﹤0.01%	2158
2020 Q2	$360K	Buy	57,355 +36,033	+169%	+$138K	﹤0.01%	2239
2020 Q1	$39K	Sell	21,322 -5,083	-19%	-$14.6K	﹤0.01%	2685
2019 Q4	$89K	Buy	26,405 +2,916	+12%	+$6.95K	﹤0.01%	2631
2019 Q3	$50K	Hold	23,489	–	–	﹤0.01%	2737
2019 Q2	$80K	Hold	23,489	–	–	﹤0.01%	2605
2019 Q1	$111K	Buy	23,489 +3,670	+19%	+$9.63K	﹤0.01%	2459
2018 Q4	$47K	Buy	19,819 +3,437	+21%	+$11.2K	﹤0.01%	2722
2018 Q3	$72K	Buy	16,382 +3,414	+26%	+$18.9K	﹤0.01%	2609
2018 Q2	$93K	Buy	+12,968	New	+$88.2K	﹤0.01%	2521
2017 Q2	–	Sell	-9,032	Closed	-$36K	–	3401
2017 Q1	$36K	Sell	9,032 -504	-5%	-$2.53K	﹤0.01%	2935
2016 Q4	$48K	Buy	9,536 +4,628	+94%	+$27.8K	﹤0.01%	2900
2016 Q3	$37K	Sell	4,908 -946	-16%	-$6.37K	﹤0.01%	2660
2016 Q2	$34K	Hold	5,854	–	–	﹤0.01%	2669
2016 Q1	$31K	Hold	5,854	–	–	﹤0.01%	2582
2015 Q4	$51K	Hold	5,854	–	–	﹤0.01%	2453
2015 Q3	$48K	Hold	5,854	–	–	﹤0.01%	2473
2015 Q2	$100K	Buy	+5,854	New	+$75.2K	﹤0.01%	2114